The researchers, in collaboration with researchers from Cayman Chemical, found that when immunotherapy revs up the immune T-cells, it then enhances oxidized lipids in the tumor cells, which leads to ferroptosis. Increased ferroptosis made immunotherapy treatment more effective at killing the cancer, based on studies in mice and human cancer cells.